Picture of Calmark Sweden AB logo

CALMA B Calmark Sweden AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Calmark: Neo-Bilirubin To Obtain CE Mark Approval In January 2020

Dec 23 (Reuters) - Calmark Sweden AB  CALMAb.TE :
    * CALMARK'S PRODUCT NEO-BILIRUBIN WILL OBTAIN CE MARK
APPROVAL IN
JANUARY 2020
    * PARTIAL STUDY OF VERIFICATION AND VALIDATION PROCESS STILL
REMAINS, AND STUDY AT SÖDERSJUKHUSET IS NOT FINISHED

Source text for Eikon:  ID:nWkr5sGNzg 
Further company coverage:  CALMAb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Calmark Sweden AB

See all news